ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway

Chen, Bonan; Song, Yue; Zhan, Yujuan; Zhou, Shikun; Ke, Junzi; Ao, Weizhen; Zhang, Yigan; Liang, Qiqi; He, Minhui; Li, Shuhui; Xie, Fuda; Huang, Haonan; Chan, Wai Nok; Cheung, Alvin H. K.; Ma, Brigette B. Y.; Kang, Wei; To, Ka Fai*; Xiao, Jianyong*广州中医药大学; 兰州大学; 1
Cancer Letters2022-9-1DOI: 10.1016/j.canlet.2022.215783
19被引5阅读
引用收藏
分享

摘要

Few drugs alleviate non-small cell lung cancer (NSCLC) metastasis effectively. Small molecular screening demonstrated that fangchinoline (Fan) reversed epithelial-mesenchymal transition (EMT) in NSCLC cells, inhibiting cell invasion and migration. RNA sequencing (RNA-seq) of Fan-treated NSCLC cells revealed that Fan potently quenched the NADP(+) metabolic process. Molecular docking analysis revealed that Fan directly and specifically targeted NOX4. NOX4 was associated with poor prognosis in NSCLC in both The Cancer Genome Atlas (TCGA) and Hong Kong cohorts. In mitochondrial DNA-depleted rho(0) NSCLC cells, Fan decreased cytosolic reactive oxygen species (ROS) to inhibit the Akt-mTOR signaling pathway by directly promoting NOX4 degradation. In TCGA and Hong Kong cohorts, NOX4 upregulation acted as a driver event as it positively correlated with metastasis and oxidative stress. Single-cell RNA-seq indicated that NOX4 was overexpressed, especially in cancer cells, cancer stem cells, and endothelial cells. In mice, Fan significantly impeded subcutaneous xenograft formation and reduced metastatic nodule numbers in mouse lung and liver. Drug sensitivity testing demonstrated that Fan suppressed patient-derived organoid growth dose-dependently. Fan is a potent small molecule for alleviating NSCLC metastasis by directly targeting NOX4 and is a potential novel therapeutic agent.

学科与关键词

关键词
FangchinolineNOX4Cytosolic ROSNon-small cell lung cancer
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancer Letters
发表日期
2022-09-01
卷期
第 543 卷
页码
215783
DOI
10.1016/j.canlet.2022.215783
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773953, 82074070]; Guangdong Natural Science Foundation [2017A030313477]; Medical Science and Technology Research Fund of Guangdong Province [A2020293]; Characteristic Innovation Project of the Guangdong Provincial Average University [2019GKTSCX045]; CUHK Comprehensive Precision Oncology Program (Kingboard PROCURE Program)

作者

  • C

    Chen, Bonan (第一作者)

    guangzhou univ chinese med · chinese univ hong kong

  • S

    Song, Yue

    guangzhou univ chinese med

查看全部 18 位作者收起作者
  • Z

    Zhan, Yujuan

    guangzhou univ chinese med

  • Z

    Zhou, Shikun

    guangzhou univ chinese med

  • K

    Ke, Junzi

    guangzhou univ chinese med · shanghai tech univ

  • A

    Ao, Weizhen

    guangzhou univ chinese med · shanghai tech univ

  • Z

    Zhang, Yigan

    1 · lanzhou univ

  • L

    Liang, Qiqi

    guangzhou univ chinese med

  • H

    He, Minhui

    guangzhou univ chinese med

  • L

    Li, Shuhui

    guangzhou univ chinese med

  • X

    Xie, Fuda

    guangzhou univ chinese med

  • H

    Huang, Haonan

    guangzhou univ chinese med

  • C

    Chan, Wai Nok

    chinese univ hong kong

  • C

    Cheung, Alvin H. K.

    chinese univ hong kong

  • M

    Ma, Brigette B. Y.

    chinese univ hong kong

  • K

    Kang, Wei

    chinese univ hong kong

  • T

    To, Ka Fai (通讯)

    chinese univ hong kong

  • X

    Xiao, Jianyong (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417